Nationwide Fund Advisors lowered its holdings in shares of RTI Surgical, Inc. (NASDAQ:RTIX) by 3.0% in the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 81,696 shares of the medical equipment provider’s stock after selling 2,495 shares during the period. Nationwide Fund Advisors owned about 0.14% of RTI Surgical worth $478,000 as of its most recent SEC filing.
Several other hedge funds have also added to or reduced their stakes in RTIX. Cigna Investments Inc. New bought a new position in shares of RTI Surgical during the second quarter valued at $105,000. First Quadrant L P CA bought a new position in shares of RTI Surgical during the second quarter valued at $137,000. American International Group Inc. raised its stake in shares of RTI Surgical by 7.0% during the first quarter. American International Group Inc. now owns 35,371 shares of the medical equipment provider’s stock valued at $141,000 after acquiring an additional 2,327 shares during the last quarter. Thompson Davis & CO. Inc. raised its stake in shares of RTI Surgical by 138.8% during the second quarter. Thompson Davis & CO. Inc. now owns 25,077 shares of the medical equipment provider’s stock valued at $147,000 after acquiring an additional 14,577 shares during the last quarter. Finally, Bank of America Corp DE raised its stake in shares of RTI Surgical by 6.4% during the first quarter. Bank of America Corp DE now owns 39,786 shares of the medical equipment provider’s stock valued at $159,000 after acquiring an additional 2,389 shares during the last quarter. 70.03% of the stock is owned by hedge funds and other institutional investors.
In other news, Director Nicholas J. Valeriani bought 5,500 shares of the stock in a transaction that occurred on Monday, August 21st. The stock was acquired at an average price of $4.70 per share, with a total value of $25,850.00. Following the completion of the purchase, the director now directly owns 47,754 shares of the company’s stock, valued at $224,443.80. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP John N. Varela bought 12,000 shares of the stock in a transaction that occurred on Friday, August 11th. The shares were purchased at an average cost of $4.85 per share, with a total value of $58,200.00. Following the purchase, the executive vice president now directly owns 47,998 shares of the company’s stock, valued at $232,790.30. The disclosure for this purchase can be found here. 4.90% of the stock is owned by company insiders.
COPYRIGHT VIOLATION WARNING: “Nationwide Fund Advisors Has $478,000 Stake in RTI Surgical, Inc. (RTIX)” was published by Community Financial News and is owned by of Community Financial News. If you are accessing this piece on another domain, it was stolen and republished in violation of US & international copyright & trademark laws. The original version of this piece can be read at https://www.com-unik.info/2017/11/05/nationwide-fund-advisors-has-478000-stake-in-rti-surgical-inc-rtix.html.
RTI Surgical, Inc. (NASDAQ:RTIX) opened at $4.80 on Friday. RTI Surgical, Inc. has a 52 week low of $2.50 and a 52 week high of $6.00. The firm has a market cap of $285.64, a price-to-earnings ratio of 120.00, a P/E/G ratio of 5.82 and a beta of 1.73. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.03 and a current ratio of 3.00.
RTI Surgical (NASDAQ:RTIX) last announced its earnings results on Thursday, November 2nd. The medical equipment provider reported $0.01 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.01. RTI Surgical had a net margin of 1.01% and a return on equity of 2.35%. The business had revenue of $66.69 million during the quarter, compared to the consensus estimate of $65.63 million. The company’s quarterly revenue was up .2% compared to the same quarter last year. analysts expect that RTI Surgical, Inc. will post 0.05 EPS for the current fiscal year.
Several equities analysts have recently issued reports on RTIX shares. BidaskClub downgraded shares of RTI Surgical from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, July 25th. Zacks Investment Research downgraded shares of RTI Surgical from a “hold” rating to a “sell” rating in a research note on Thursday, October 5th.
About RTI Surgical
RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.
What are top analysts saying about RTI Surgical Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for RTI Surgical Inc. and related companies.